The weekly litigation news digest is live. Subscribe now

IP Verse

Pharmaceutical Composition Capable Of The Incorporation Of Lenalidomide In Various Crystalline Modifications - EP3135275

The patent EP3135275 was granted to Grindeks on May 13, 2020. The application was filed on Aug 27, 2015 under application number EP15182621A. The patent is currently recorded with a legal status of "Revoked".

EP3135275

GRINDEKS
Application Number
EP15182621A
Filing Date
Aug 27, 2015
Status
Revoked
Aug 11, 2023
Publication Date
May 13, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
BACHELINFeb 11, 2021HOFFMANN EITLEADMISSIBLE
HOFFMANN EITLEFeb 11, 2021HOFFMANN EITLEADMISSIBLE
SYNTHONFeb 11, 2021HAMM & WITTKOPPADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2011060010
DESCRIPTIONWO03097040
DESCRIPTIONWO2010056384
DESCRIPTIONWO2011018101
DESCRIPTIONWO2013012485
OPPOSITIONWO2005023192
OTHEREP3315275
OTHERWO03097040
OTHERWO2005023192
OTHERWO2011033468
OTHERWO2011061611
OTHERWO2011111053
SEARCHDE102008057284
SEARCHWO2014160686

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents